Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Cited In for PubMed (Select 18499698)

1.

NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.

Zhang K, Gao L, Wu Y, Chen J, Lin C, Liang S, Su J, Ye J, He X.

Int J Clin Exp Med. 2015 Jun 15;8(6):9177-91. eCollection 2015.

2.

Gene-by-Environment Interactions in Pancreatic Cancer: Implications for Prevention.

Jansen RJ, Tan XL, Petersen GM.

Yale J Biol Med. 2015 Jun 1;88(2):115-26. eCollection 2015 Jun. Review.

3.

Pharmacogenetics of SULT1A1.

Daniels J, Kadlubar S.

Pharmacogenomics. 2014 Nov;15(14):1823-1838.

PMID:
25493573
4.

Polymorphisms in xenobiotic metabolizing genes, intakes of heterocyclic amines and red meat, and postmenopausal breast cancer.

Lee HJ, Wu K, Cox DG, Hunter D, Hankinson SE, Willett WC, Sinha R, Cho E.

Nutr Cancer. 2013;65(8):1122-31. doi: 10.1080/01635581.2013.824991. Epub 2013 Oct 7.

5.

CYP1A2 rs762551 polymorphism contributes to cancer susceptibility: a meta-analysis from 19 case-control studies.

Wang H, Zhang Z, Han S, Lu Y, Feng F, Yuan J.

BMC Cancer. 2012 Nov 19;12:528. doi: 10.1186/1471-2407-12-528.

6.

Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis.

Momi N, Kaur S, Ponnusamy MP, Kumar S, Wittel UA, Batra SK.

Carcinogenesis. 2012 Sep;33(9):1617-28. doi: 10.1093/carcin/bgs186. Epub 2012 May 23. Review.

7.

Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk.

Jang JH, Cotterchio M, Borgida A, Gallinger S, Cleary SP.

Carcinogenesis. 2012 Apr;33(4):818-27. doi: 10.1093/carcin/bgs028. Epub 2012 Feb 2. Erratum in: Carcinogenesis. 2012 Jul;33(7):1430.

8.

The role of tobacco-derived carcinogens in pancreas cancer.

Lochan R, Reeves HL, Daly AK, Charnley RM.

ISRN Oncol. 2011;2011:249235. doi: 10.5402/2011/249235. Epub 2011 Jul 17.

9.

NATb/NAT1*4 promotes greater arylamine N-acetyltransferase 1 mediated DNA adducts and mutations than NATa/NAT1*4 following exposure to 4-aminobiphenyl.

Millner LM, Doll MA, Cai J, States JC, Hein DW.

Mol Carcinog. 2012 Aug;51(8):636-46. doi: 10.1002/mc.20836. Epub 2011 Aug 11.

10.

Functional effects of genetic polymorphisms in the N-acetyltransferase 1 coding and 3' untranslated regions.

Zhu Y, States JC, Wang Y, Hein DW.

Birth Defects Res A Clin Mol Teratol. 2011 Feb;91(2):77-84. doi: 10.1002/bdra.20763. Epub 2011 Feb 2.

11.

An overview of genetic polymorphisms and pancreatic cancer risk in molecular epidemiologic studies.

Lin Y, Yagyu K, Egawa N, Ueno M, Mori M, Nakao H, Ishii H, Nakamura K, Wakai K, Hosono S, Tamakoshi A, Kikuchi S.

J Epidemiol. 2011;21(1):2-12. Epub 2010 Nov 6. Review.

12.

Lack of association of the N-acetyltransferase NAT1*10 allele with prostate cancer incidence, grade, or stage among smokers in Finland.

Kidd LR, Hein DW, Woodson K, Taylor PR, Albanes D, Virtamo J, Tangrea JA.

Biochem Genet. 2011 Feb;49(1-2):73-82. doi: 10.1007/s10528-010-9386-4. Epub 2010 Oct 8.

13.

Housekeeping genes in prostate tumorigenesis.

Byun J, Logothetis CJ, Gorlov IP.

Int J Cancer. 2009 Dec 1;125(11):2603-8. doi: 10.1002/ijc.24680.

14.

The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study.

Andersen V, Agerstjerne L, Jensen D, Østergaard M, Saebø M, Hamfjord J, Kure E, Vogel U.

BMC Med Genet. 2009 Feb 27;10:18. doi: 10.1186/1471-2350-10-18.

15.

DNA repair gene polymorphisms and risk of pancreatic cancer.

Li D, Suzuki H, Liu B, Morris J, Liu J, Okazaki T, Li Y, Chang P, Abbruzzese JL.

Clin Cancer Res. 2009 Jan 15;15(2):740-6. doi: 10.1158/1078-0432.CCR-08-1607.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk